Physician profile
John Kintiroglou
NPI 1528198645
$2,261.70
in general payments reported to CMS, 2019-2025
19 companies · $598 in 2025
The $598 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $169 · 2021: $212 · 2022: $590 · 2023: $253 · 2024: $316 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,167.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $523.57 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $415.75 | 2019-2025 | Bexsero, Penmenvy, Pediarix |
| Pfizer INC. | $220.18 | 2019-2025 | |
| Baxter Healthcare | $182.71 | 2022 | |
| Sanofi Pasteur INC. | $176.50 | 2020-2025 | |
| Cranial Technologies, INC | $176.36 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $82.08 | 2021-2024 | Qelbree, Qelbree |
| Tris Pharma INC | $80.86 | 2020-2022 | |
| Kaleo, INC. | $68.53 | 2022-2024 | Auvi-Q |
| Neos Therapeutics, LP | $61.87 | 2023-2025 | Cotempla Xr-Odt |
| Sanofi-Aventis U.S. LLC | $61.74 | 2024-2025 | |
| Cumberland Pharmaceuticals, INC. | $49.15 | 2024-2025 | Kristalose |
| Seqirus USA INC | $45.62 | 2022-2025 | Flucelvax |
| Alk-Abello, INC | $31.23 | 2025 | Neffy |
| Sobi, INC | $24.94 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $16.80 | 2024 | Flumist Quadrivalent |
| Aytu Biopharma, INC. | $15.48 | 2022 | |
| Cognoa, INC. | $15.40 | 2022 | |
| Alexion Pharmaceuticals, INC. | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kintiroglou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.